MYBL2 and cancer: Each of these transcription factors harbors oncogenic or tumor-promoting functions and some of them were reported to be overexpressed in cancer, including overexpression of E2F1, E2F6 [40], FOXM1, and MYBL2 [50] in glioblastomas.